Company profile

Hemab Therapeutics

The next generation of therapeutics for bleeding and thrombotic disorders

Industry
Biotechnology Research
Employees
94
Headquarters
Frederiksberg, Capital Region of Denmark
Founded
2020
LinkedIn followers
11,942
Office locations
2

Hemab Therapeutics company summary

Hemab Therapeutics is a company in the Biotechnology Research industry, headquartered in Frederiksberg, Capital Region of Denmark, founded in 2020. On LinkedIn the company has around 94 employees and 11,942 followers. The company lists 2 office locations. Its listed specialties include Biotech.

What technology does Hemab Therapeutics use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Hemab Therapeutics

Hemab is a clinical-stage biotech company developing the first prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders. Based in Cambridge, Massachusetts and Copenhagen, Denmark, Hemab is progressing a pipeline of monoclonal and bispecific antibody-based therapeutics to transform the treatment paradigm for patients with high unmet need. The company’s strategic guidance, Hemab 1-2-5, targets the development of 5 clinical assets by 2025 to deliver long-awaited innovation for patients with high unmet need blood clotting disorders like Glanzmann Thrombasthenia, factor VII deficiency, Bernard Soulier Syndrome, Von Willebrand Disease and other serious disorders. Learn more at hemab.com.

Specialties

Biotech

Where is Hemab Therapeutics located?

Hemab Therapeutics lists 2 office locations.

Frederiksberg, Capital Region of Denmark, DKHQ
Nordre Fasanvej 215
Cambridge, Massachusetts, US
101 Main Street

Compare companies similar to Hemab Therapeutics

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
Hemab Therapeutics
hemab.com
Biotechnology Research942020Frederiksberg, Capital Region of Denmark
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about Hemab Therapeutics

What does Hemab Therapeutics do?

Hemab is a clinical-stage biotech company developing the first prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders. Based in Cambridge, Massachusetts and Copenhagen, Denmark, Hemab is progressing a pipeline of monoclonal and bispecific antibody-based therapeutics to transform the treatment paradigm for patients with high unmet need. The company’s strategic guidance, Hemab 1-2-5, targets the development of 5 clinical assets by 2025 to deliver long-awaited innovation for patients with high unmet need blood clotting disorders like Glanzmann Thrombasthenia, factor VII deficiency, Bernard Soulier Syndrome, Von Willebrand Disease and other serious disorders. Learn more at hemab.com.

How many employees does Hemab Therapeutics have?

Hemab Therapeutics has around 94 employees on LinkedIn.

Where is Hemab Therapeutics headquartered?

Hemab Therapeutics is headquartered in Frederiksberg, Capital Region of Denmark.

Where does Hemab Therapeutics have offices?

Hemab Therapeutics lists 2 office locations, including Frederiksberg, Capital Region of Denmark, DK; Cambridge, Massachusetts, US.

When was Hemab Therapeutics founded?

Hemab Therapeutics was founded in 2020.

Build a lead list from companies like Hemab Therapeutics

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.